Living with stable angina: patients' pathway and needs in angina.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
May 2020
Historique:
pubmed: 25 3 2020
medline: 20 1 2021
entrez: 25 3 2020
Statut: ppublish

Résumé

There is evidence that stable angina patients may suffer from emotional disorders that further impair their quality of life. However, the emotional experience of living with stable angina from the patient's perspective still has to be explored. Thus, the main aim of this study was to explore patients' emotional experience of having stable angina and their reported needs during the pathway from the first symptoms, through the process of diagnosis, to management and related lifestyle changes. A survey was conducted in 75 chronic ischemic heart disease patients with angina (Brazil, China, Romania, Russia, and Turkey) using a 75-min, face-to-face in-depth interview. Patients' responses highlighted the need to increase individuals' awareness on the first signs and symptoms of the disease. The survey also showed that chronic stable angina patients need constant emotional support to overcome stress, anxiety, and depression. Finally, this study suggests the need to offer greater space for dialogue with healthcare professionals to get more comprehensive and 'patient-friendly' information.

Identifiants

pubmed: 32205502
doi: 10.2459/JCM.0000000000000954
pii: 01244665-202005000-00005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-382

Références

Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation 2014; 129:1493–1501.
Tarkin JM, Kaski JC. Pharmacological treatment of chronic stable angina pectoris. Clin Med 2013; 13:63–70.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 28 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2163–2196.
Kureshi F, Shafiq A, Arnold SV, et al. The prevalence and management of angina among patients with chronic coronary artery disease across US outpatient cardiology practices: insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study. Clin Cardiol 2017; 40:6–10.
Peterson E. The burden of angina pectoris and its complications [corrected]. Clin Cardiol 2007; 30: (2 Suppl 1): 110–115.
Huqi A, Morrone D, Guarini G, Capozza P, Orsini E, Marzilli M. Stress testing after complete and successful coronary revascularization. Can J Cardiol 2016; 32:986e23-9.
Ben-Yehuda O, Kazi DS, Bonafede M, et al. Angina and associated healthcare costs following percutaneous coronary intervention: a real-world analysis from a multipayer database. Catheter Cardiovasc Interv 2016; 88:1017–1024.
Jespersen L, Abildstrøm SZ, Hvelplund A, Prescott E. Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol 2013; 102:571–581.
Padala SK, Lavelle MP, Sidhu MS, et al. Antianginal therapy for stable ischemic heart disease: a contemporary review. J Cardiovasc Pharmacol Ther 2017; 22:499–510.
Mozaffarian D, Bryson CL, Spertus JA, McDonell MB, Fihn SD. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J 2003; 146:1015–1022.
Steg PG, Greenlaw N, Tendera M, et al. Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. JAMA Intern Med 2014; 174:1651–1659.
McKee MM, Winters PC, Fiscella K. Low education as a risk factor for undiagnosed angina. J Am Board Fam Med 2012; 25:416–421.
Smith R, Frazer K, Hyde A, O’Connor L, Davidson P. Heart disease never entered my head’: women's understanding of coronary heart disease risk factors. J Clin Nurs 2018; 27:3953–3967.
Gravely-Witte S, De Gucht V, Heiser W, Grace SL, Van Elderen T. The impact of angina and cardiac history on health-related quality of life and depression in coronary heart disease patients. Chronic Illn 2007; 3:66–76.
Kelly S, Martin S, Kuhn I, Cowan A, Brayne C, Lafortune L. Barriers and facilitators to the uptake and maintenance of healthy behaviours by people at mid-life: a rapid systematic review. PLoS One 2016; 11:e0145074.
Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med 1995; 40:379–392.
Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290:215–221.
Szpakowski N, Bennell MC, Qiu F, et al. Clinical impact of subsequent depression in patients with a new diagnosis of stable angina: a population-based study. Circ Cardiovasc Qual Outcomes 2016; 9:731–739.
Carney RM, Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol 2017; 14:145–155.
Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol 2007; 49:2021–2027.
Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019. pii:ehz425.
Sykes CM. Patient satisfaction of the Angina Plan in a rapid access chest pain clinic. Br J Cardiol 2006; 13:361–362.
Tinson D, Swartzman S, Lang K, Spense S, Todd L. Clinical and psychological outcomes of an angina management programme. Br J Cardiol 2016; 23:61–64.
Zeng W, Stason WB, Fournier S, et al. Benefits and costs of intensive lifestyle modification programs for symptomatic coronary disease in Medicare beneficiaries. Am Heart J 2013; 165:785–792.
McGillion M, Arthur H, Victor JC, Watt-Watson J, Cosman T. Effectiveness of psychoeducational interventions for improving symptoms, health-related quality of life, and psychological well being in patients with stable angina. Curr Cardiol Rev 2008; 4:1–11.
Patel PA, Khan M, Yau C, Thapar S. The short- and long-term impact of psychotherapy in patients with chronic, refractory angina. Br J Cardiol 2016; 23:57–60.
Fanaroff AC, Prather K, Brucker A, et al. Relationship between optimism and outcomes in patients with chronic angina pectoris. Am J Cardiol 2019; 123:1399–1405.
Sabaté E. WHO adherence to long term therapies project, global adherence IN. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
Desai NR, Choudhry NK. Impediments to adherence to post myocardial infarction medications. Curr Cardiol Rep 2013; 15:322.
Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297:177–186.
Borrás X, Garcia-Moll X, Gómez-Doblas JJ, Zapata A, Artigas R. AVANCE study researchers. Stable angina in Spain and its impact on quality of life. The AVANCE registry. Rev Esp Cardiol (Engl Ed) 2012; 65:734–741.
Qintar M, Spertus JA, Gosch KL, et al. Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease. Eur Heart J Qual Care Clin Outcomes 2016; 2:208–214.
Arnold SV, Grodzinsky A, Gosch KL, et al. Predictors of physician under-recognition of angina in outpatients with stable coronary artery disease. Circ Cardiovasc Qual Outcomes 2016; 9:554–559.
Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes 2014; 7:640–647.
Alexander KP, Stadnyuk O, Arnold SV, Mark DB, Ohman EM, Anstrom KJ. Assessing quality of life and medical care in chronic angina: an internet survey. Interact J Med Res 2016; 5:e12.

Auteurs

Ilaria Spoletini (I)

Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome.

Roberto Ferrari (R)

Cardiological University Centre of Ferrara, University of Ferrara, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

Giuseppe M C Rosano (GMC)

Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH